Comparative analysis of renal impairment in HIV-positive and HIV-negative individuals at Kono government hospital, Sierra Leone
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20261744Keywords:
HIV, Renal impairment, Diabetes, Hypertension and prevalenceAbstract
Background: Non-communicable disease is of major concern affecting a significant portion of the global population. It is a serious and gradual condition marked by the progressive deterioration of kidney function. In recent years, Renal impairment has emerged as a clinically relevant and significant issue. The aim of this study was to compare analysis of renal impairment in individual with HIV, diabetes, and hypertension.
Methods: This was a cross-section quantitative study. It was conducted from June to September 2024. A total of 275 participants were selected. Serum creatine and CD4 counts were measured in HIV-Positive individuals, and the eGFR was calculated using the CKD-Epi 2021 formula. Data analysis was done using SPSS Version 16.
Results: Among the study population, 158 participants (57.5%) were HIV-Positive, while 62 (22.5%) and 55(20%) were HIV-Negative individuals diagnosed with hypertension and diabetes, respectively. The overall prevalence of renal impairment was found to be 34.2% among HIV-Positive, 30.6% among hypertensive participants, and 38.2% among those with diabetes. Participants aged 31-40 years demonstrated a significant higher likelihood of renal impairment (AOR=5.37, 95% CI: 2.414-12.489), and for those over 50 years (AOR=4.93; 95% CI:1.491-16.351). Among diabetic participants, older age was also significantly associated with renal impairment (OR=6.379; 95% CI: 1.129-36.060). Furthermore, hypertensive females were identified as having an increased risk of developing renal impairment.
Conclusions: The study highlights a concerning prevalence of renal impairment among participants, with age and gender as significant risk factors. These findings underscore the importance of monitoring renal function in at-risk populations.
References
Kidney disease: a global health priority. Nat Rev Nephrol. 2024;20:421-3.
Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473-85.
Jensen SK, Heide-Jørgensen U, Gammelager H, Birn H, Christiansen CF. Acute kidney injury duration and 20-year risks of CKD and cardiovascular disease. Kidney Int Rep. 2024;9(4):817-29.
Guo J, Jiao W, Xia S, Xiang X, Zhang Y, Ge X, et al. The global, regional, and national patterns of change in the burden of chronic kidney disease from 1990 to 2021. BMC Nephrol. 2025;26:136.
Jäger KU, Kovesdy CP, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019.
Msilanga D, Msangi E. Prevalence and predictors of kidney dysfunction among people living with HIV in Tanzania. PLOS Glob Public Health. 2025;5(8):e0005011.
Bonilla M, Jhaveri KD, Izzedine H. Anaplastic lymphoma kinase inhibitors and their effect on the kidney. Clin Kidney J. 2022.
Thongprayoon C, Cheungpasitporn W, Yap JQ, Qian Q. Increased mortality risk associated with serum sodium variations and borderline hypo- and hypernatremia in hospitalized adults. Nephrol Dial Transplant. 2020;35(10):1746-52.
Kumar S, Fan SLS, Raftery MJ, Yaqoob MM. Long-term outcome of patients with autosomal dominant polycystic kidney disease receiving peritoneal dialysis. Kidney Int. 2008;74(7):946-51.
Idowu A, Aremu AO, Olumide A, Ogunlaja AO. Substance abuse among students in selected secondary schools of an urban community of Oyo-state, South West Nigeria: implication for policy action. Afr Health Sci. 2018;18(3):776-85.
Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep. 2024.
Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016.
Asmelash D, Nigatie M. Chronic kidney disease and its associated factors in HIV-infected individuals: a comparison of antiretroviral therapy naïve and experienced patients. Front Med (Lausanne). 2024;11:1455688.
Kefeni BT, Hajito KW, Getnet M. Renal function impairment and associated factors among adult HIV-positive patients attending antiretroviral therapy clinic in Mettu Karl Referral Hospital: cross-sectional study. HIV/AIDS Res Palliat Care. 2021;13:e301748.
Umeizudike TO, Oparah AO, Oduwole OA, Akinbami AA, Obaseki AO. Prevalence of chronic kidney disease in HIV positive patients in Lagos, South-West Nigeria. Nephrol Res Rev. 2012;4(1):22-6.
Onodugo OD, Iroezindu AO, Chukwuonye CO, Nwokediuko AO, Ijoma CA. Baseline renal function among antiretroviral therapy-naive, HIV-infected patients in southeast Nigeria. J Int Assoc Provid AIDS Care. 2014;13(5):476-80.
Kefeni BT, Hajito KW, Getnet M. Renal function impairment and associated factors among adult HIV-positive patients attending antiretroviral therapy clinic in Mettu Karl Referral Hospital: cross-sectional study. HIV/AIDS Res Palliat Care. 2021;13:e301748.
Ephraim RKD, Biekpe S, Sakyi SA, Adoba P, Agbodjakey H, Antoh EO. Prevalence of chronic kidney disease among the high-risk population in South-Western Ghana: a cross-sectional study. Can J Kidney Health Dis. 2015;2:33.
Zhang X, Kong J, Yun K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies. Int J Endocrinol. 2020;2020:2315607.
Mpondo BCT, Neilson E, Ernest A. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol. 2016;17:1.
Russell JBW, Kamara SAD, Bangura MS, Kanu JS, Koroma AR, Sesay FSS, et al. Burden of cardiometabolic risk factors and preclinical target organ damage among adults in Freetown, Sierra Leone: a community-based health-screening survey. BMJ Open. 2023;13(5):e067643.
Ulasi II, Ijoma CK, Onodugo OD, Arodiwe EB, Ifebunandu NA, Okoye JU. Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria. Kidney Int Suppl (2011). 2013;3(2):195-201.
Yang L, Li S, Zhang Y, Wang H, Wang J, Liu X, et al. Global, regional, and national burden of hypertension-induced cardiorenal disease, 1990–2021 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health. 2025;25:23742.
Kefeni BT, Hajito KW, Getnet M. Renal function impairment and associated factors among adult HIV-positive patients attending antiretroviral therapy clinic in Mettu Karl Referral Hospital: cross-sectional study. HIV/AIDS Res Palliat Care. 2021;13:e301748.
Elendu C, Eze NO, Okafor CU, Nwosu IC, Nnaji UA. Comprehensive review of current management guidelines of chronic kidney disease. Medicine (Baltimore). 2023;102(23):e33984.
Matoba K, Takeda Y, Nagai Y, Yokota T, Utsunomiya K, Nishimura R. Targeting redox imbalance as an approach for diabetic kidney disease. Biomedicines. 2020;8(2):40.
Tannor EK, Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adu-Gyamfi R, Plange-Rhule J. Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: a multicenter cross-sectional study. J Clin Hypertens (Greenwich). 2019;21(10):1542-50.
Assaram S, Mashamba-Thompson TP, Magula NP. Risk factors and co-morbidities associated with changes in renal function among antiretroviral treatment-naïve adults in South Africa: a chart review. S Afr J HIV Med. 2018;19(1):770.
Obiri-Yeboah D, Agyarko-Poku KA, Tannor EK, Amoah SS, Amponsah SK, Owiredu SA. Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana. BMC Nephrol. 2018;19:1130.
Odubela OO, Odunukwe NN, Peer N, Musa AZ, Salako BL, Kengne AP. Prevalence and associations of chronic kidney disease among antiretroviral therapy-naïve persons living with HIV in Lagos, Nigeria. BMC Nephrol. 2024;25:3711.
Downloads
Published
How to Cite
Issue
Section
